CORDOVA,
Tenn., March 28, 2024 /PRNewswire/
-- Aesthetic Management Partners LLC, a manufacturer of
skin-based solutions and a provider of energy-based devices
announces its collaboration with Croma (Croma-Pharma®
GmbH), a global player in the minimally invasive aesthetics market
and a leading European manufacturer of premium quality hyaluronic
acid syringes, to distribute its revolutionary skincare line EXO|E™
Skin Revitalizing Complex to the EU market and Switzerland. With this partnership, Aesthetic
Management Partners continues to expand its footprint and introduce
the EXO|E™ product line to providers and their patients.
Aesthetic Management Partners
Announces Partnership with Croma-pharma to Distribute Plant-Based
Exosome Tech to Europe
EXO|E™ – The Rising Star in the Aesthetic
Field
The EXO|E™ Skin Revitalizing Complex line of products is
derived from plant-based secretory factors that plant-derived
exosomes, liposomes, growth factors and anti-stressing factors that
help to support and supplement the skin's balance.
Plant-based exosomes have recently taken the spotlight in
scientific and medical communities, generating an unprecedented
level of excitement.
"I am thrilled to announce our partnership with Croma Pharma,
bringing the revolutionary EXO|E product line to aesthetic
practitioners across Europe and
Switzerland," said
Erik Dowell, CEO and Founder of
Aesthetic Management Partners. "This collaboration represents a
significant stride in advancing innovation and enhancing patient
outcomes within the aesthetic industry. With Croma Pharma's
extensive reach and our shared commitment to excellence, we are
poised to empower practitioners with cutting-edge solutions,
transforming the landscape of aesthetic care throughout the
region", says AMP CEO and Founder Erik
Dowell.
By adding the revolutionary EXO|E™ product line to the
portfolio, Croma is now offering the latest trend in the aesthetic
field. "We are excited to embark on this collaborative journey
with Aesthetic Management Partners", said Andreas Prinz, CEO of Croma Pharma.
"Together, we have the opportunity to add a revolutionary
product line to our portfolio, empowering our customers to bring
additional value to their patients."
Both companies are committed to working closely together to
ensure seamless integration and maximum impact.
About EXO|E™ Skin Revitalizing Complex
Applying a
biomimetic approach to the science of beauty, the EXO|E™ Skin
Revitalizing Complex is a consortium of plant-based secretory
factors, including plant-derived exosomes, liposomes, growth
factors and anti-stressing factors that helps to support and
supplements the skin's balance. EXO|E™ is based on a
patent-protected biofriendly formula that helps ensure perfect
compatibility with the skin. The topical treatment protocol is a
3-step regimen including D|TOX™, EXO|E™, and RE|PAIR™, which are
applied over a 15-day regimen for in-office and at-home use.
Physicians are using the innovative product line to prepare the
skin for in-office procedures like Microneedling, RF Microneedling,
Skin Resurfacing, as well as many other aesthetic treatments and
also as a post-treatment cosmetic regimen.The complete skincare
portfolio is water based, 100% natural, and vegan.
For more information about EXO|E Skin Revitalizing Complex visit
www.aesthetifcmanagementpartners.com
About Aesthetic Management Partners
Aesthetic
Management Partners is a leading manufacturer of transformative
aesthetic treatment solutions. The company's portfolio includes
plant based patented technology for skin and hair revitalization
and complemented by a portfolio of aesthetic energy-based devices.
Aesthetic Management Partners directly distributes its products in
the US and Canada, and through
international distributors in over 60 countries. For additional
information, visit www.aestheticmanagementpartners.com.
About Croma
Croma is a global player in the
minimally invasive aesthetics market and a leading European
manufacturer of premium quality hyaluronic acid syringes. The
company offers a comprehensive and innovative aesthetics portfolio
including botulinum toxin, fillers, lifting threads and
biostimulators complemented by its own skincare brand. Founded in
1976 by a pharmacist couple, Croma-Pharma GmbH is a family company
headquartered in Austria where it
also operates its manufacturing plant. With 550 employees, 13
subsidiaries in Europe and
Brazil, two joint ventures and 60
exclusive export partners, it distributes its products in 80
markets globally, including the US/Canada, China, and Australia/New
Zealand. It also operates as a contract manufacturer in
orthopedics and ophthalmology. For more information, please visit
www.cromapharma.com.
CONTACT:
Amanda Carraway, Marketing Communications
Aesthetic Management Partners
770-823-1929
Amanda.Carraway@amplifimd.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aesthetic-management-partners-announces-partnership-with-croma-pharma-to-distribute-plant-based-exosome-technology-to-europe-302101251.html
SOURCE Aesthetic Management Partners